Wickham Laboratories passes MHRA inspection

Published: 14-Jul-2017
Regulatory

Wickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of good laboratory practice accreditation

Wickham Laboratories announced the Medicine and Health Regulatory Agency (MHRA) inspection, conducted May 2017 has resulted in the issue of a new statement of good laboratory practice (GLP) compliance.

This inspection assessed Wickham’s compliance with GLP principles, reviewing various client study files, the evaluation of its quality management system, organisation, personnel and archives.

The company reported it was pleased its effort and dedication to giving its clients the highest standards of quality have been recognised by the regulatory authorities.

The certificate is available for its clients to download from the Quality Assurance section of the Wickham Laboratories website.

  • Companies:
  • Wickham Micro
See more

You may also like

Regulatory

Wickham Labs to present at Cleanroom Technology Conference 2021

Read more
The conference will be held on September 14th - 15th at the National Exhibition Centre in Birmingham

Trending Articles

  1. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Wickham Labs to present at Cleanroom Technology Conference 2021

The conference will be held on September 14th - 15th at the National Exhibition Centre in Birmingham
Regulatory

Faster turnaround time, same reliable result

Wickham Laboratories offers expedited testing!
Regulatory

Wickham Laboratories Ltd to exhibit at Pharmig 2019

Wickham Laboratories will be attending Pharmig’s 27th annual conference on 13-14 November
Regulatory

The rising importance of preservative efficacy testing

When considering the regulation and validation of pharmaceutical products, the efficacy of the active pharmaceutical ingredient (API) is often the main concern
Training & Education

Wickham Laboratories to present at Cleanroom Technology Conference 2018

Dr John McKenzie, Wickham CEO and conference speaker, will be presenting microbiological considerations in cleanroom validation
Training & Education

Free webinar: Regulatory changes in medical device development

Wickham Laboratories and Patient Guard have joined forces to host a free webinar on 23 May discussing regulatory changes in medical device development
Regulatory

Wickham Lab to exhibit at inaugural Making Pharmaceuticals Europe

The event, featuring a conference and exhibition, takes place from 13-14 March 2018 at Brussels Expo in Belgium
Subscribe now